Esaote S.p.A. – sole-shareholder company(English)

UroFusion TPUS/TRUS Smart Prostate Target Biopsy June 2022, Genova, Italy.

2022 | NaviSuite®

Abstract To evaluate the diagnostic accuracy of mpMRI and mpMRI / transrectal ultrasound (TRUS) fusion-guided targeted biopsy (FTB) against…

2018 | BiopSee®

Magnetic Resonance and Ultrasound Image Fusion Supported Transperineal Prostate Biopsy Using the Ginsburg Protocol: Technique, Learning Points, and…

2016 | BiopSee®

Transperineal prostate biopsy with ECHO-MRI fusion. Biopsee system. Initial experience

2016 | BiopSee®

TRANSPERINEAL SATURATION/FUSION BIOPSIES INTEGRATION IN HIFU PROSTATE FOCAL TREATMENT BY FOCAL ONE®

2016 | BiopSee®

Prostate Cartography: Targeted &systematic perineal stereotactic prostate biopsy using the BiopSee®platform in locating and re-locating prostate…

2016 | BiopSee®

Purpose: Diagnosis and precise risk stratification of prostate cancer (PC) is essential for individualized treatment decisions. MRI/TRUS fusion has…

2013 | BiopSee®

MRT-navigierte stereotaktische Prostatabiopsie – Echtzeitfusion von MRT und transrektalem Ultraschall zu perinealen Prostatastanzbiopsien.

The interest in fusion imaging technology for transcranial application, that is the registration of Echo-color Doppler Ultrasound (ECD) and a second…

Three-dimensional (3D) Panoramic ultrasound imaging is a Virtual Navigator option which allows the acquisition of ultrasound (US) volumes of Doppler…